Rarely metastasizing soft tissue tumours

Histopathology

Volumn 64, Issue 1, 2014, Pages 88-100

  Mangham, D Chas ^a,b   Kindblom, Lars Gunnar ^a  

^a ROYAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^b ROBERT JONES AND AGNES HUNT ORTHOPAEDIC HOSPITAL   (United Kingdom)

Author keywords

GIST; Grade; Intermediate; Melanotic schwannoma; Myoepithelioma; Myxoinflammatory fibroblastic sarcoma; PEComa; Phosphaturic mesenchymal tumour; Pseudomyogenic haemangioendothelioma; Rarely metastasizing; Sarcoma; Solitary fibrous tumour

Indexed keywords

CALPONIN; CYTOKERATIN; EARLY GROWTH RESPONSE FACTOR 1; HYALIN; PROTEIN S 100; SMOOTH MUSCLE ACTIN; STAT6 PROTEIN;

ANGIOMATOID FIBROUS HISTIOCYTOMA; ATYPICAL FIBROXANTHOMA; COMPOSITE HEMANGIOENDOTHELIOMA; DERMATOFIBROMA; DERMATOFIBROSARCOMA PROTUBERANS; DIFFERENTIAL DIAGNOSIS; FIBROSARCOMA; FIBROXANTHOMA; GENE MUTATION; GIANT CELL TUMOR; HEMANGIOENDOTHELIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; INFANTILE FIBROSARCOMA; KAPOSI SARCOMA; METASTASIS; MIXED TUMOR; MYOEPITHELIOMA; MYXOINFLAMMATORY FIBROBLASTIC SARCOMA; OSSIFYING FIBROMYXOID TUMOR; PAPILLARY INTRALYMPHATIC ANGIOENDOTHELIOMA; PHOSPHATURIC MESENCHYMAL TUMOR; PLASMA CELL GRANULOMA; PLEXIFORM FIBROHISTIOCYTIC TUMOR; PRIORITY JOURNAL; PSEUDOMYOGENIC HEMANGIOENDOTHELIOMA; RARE DISEASE; RETIFORM HEMANGIOENDOTHELIOMA; REVIEW; SOFT TISSUE TUMOR; SOLITARY FIBROUS TUMOR; TUMOR CLASSIFICATION; WORLD HEALTH ORGANIZATION;

GIST; GRADE; INTERMEDIATE; MELANOTIC SCHWANNOMA; MYOEPITHELIOMA; MYXOINFLAMMATORY FIBROBLASTIC SARCOMA; PECOMA; PHOSPHATURIC MESENCHYMAL TUMOUR; PSEUDOMYOGENIC HAEMANGIOENDOTHELIOMA; RARELY METASTASIZING; SARCOMA; SOLITARY FIBROUS TUMOUR;

HUMANS; SOFT TISSUE NEOPLASMS;

EID: 84889646029     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12310     Document Type: Review

References (47)

1. Fletcher CDM, Unni KK, Mertens F eds. World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press, 2002.
2. Fletcher CDM, Bridge JA, Pancras CW, Hogendoorn FM eds. WHO classification of tumours of soft tissue and bone. Lyon: IARC Press, 2013.
3. Doyle LA, Fletcher CD. Metastasizing 'benign' cutaneous fibrous histiocytoma: a clinicopathologic study of 16 cases. Am. J. Surg. Pathol. 2013; 37; 484-495.
4. Calonje E, Mentzel T, Fletcher CD. Cellular benign fibrous histiocytoma. Clinicopathologic analysis of 74 cases of a distinctive variant of cutaneous fibrous histiocytoma with frequent recurrence. Am. J. Surg. Pathol. 1994; 18; 668-676.
5. Lodewick E, Avermaete A, Blom WA et al. Fetal case of cellular fibrous histiocytoma: case report and review of literature. Am. J. Dermatopathol. 2013. [Epub ahead of print].
6. Somerhausen NS, Fletcher CD. Diffuse-type giant cell tumor: clinicopathologic and immunohistochemical analysis of 50 cases with extraarticular disease. Am. J. Surg. Pathol. 2000; 24; 479-492.
7. Antonescu CR, Stratakis CA, Woodruff JM. Melanotic schwannoma. In Fletcher CDM, Bridge JS, Pancras CW, Hogendoorn FM eds. WHO classification of tumours of soft tissue and bone. Lyon: IARC Press, 2013; 173.
8. Miettinen MM, Corless CL, Debiec-Rychter M et al. Gastrointestinal stromal tumours. In Fletcher CDM, Bridge JS, Pancras CW, Hogendoorn FM eds. WHO classification of tumours of soft tissue and bone. Lyon: IARC Press, 2013; 164-167.
9. Weidner N, Santa Cruz D. Phosphaturic mesenchymal tumors: a polymorphous group causing osteomalacia or rickets. Cancer 1987; 15; 1442-1454.
10. Weidner N. Review and update: oncogenic osteomalacia-rickets. Ultrastruct. Pathol. 1991; 15; 317-333.
11. Folpe AL, Fanburg-Smith JC, Billings SD et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am. J. Surg. Pathol. 2004; 28; 1-30.
12. Chong WH, Molinolo AA, Chen CC et al. Tumor-induced osteomalacia. Endocr. Relat. Cancer 2011; 8; R53-R77.
13. Yamashita T, Yoshioka M, Itoh N. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the 'ventrolateral thalamic nucleus of the brain'. Biochem. Biophys. Res. Commun. 2000; 277; 494-498.
14. Schiavi SC, Kumar R. The phosphatonin pathway: new insights in phosphate homeostasis. Kidney Int. 2004; 65; 1-14.
15. Bahrami A, Weiss SW, Montgomery E et al. RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia. Am. J. Surg. Pathol. 2009; 33; 1348-1354.
16. Leaf DE, Pereira RC, Bazari H et al. Oncogenic osteomalacia due to FGF23-expressing colon adenocarcinoma. J. Clin. Endocrinol. Metab. 2013; 98; 887-891.
17. Shelekhova KV, Kazakov DV, Hes O et al. Phosphaturic mesenchymal tumor (mixed connective tissue variant): a case report with spectral analysis. Virchows Arch. 2006; 448; 232-235.
18. Graham R, Krishnamurthy S, Oliveira A et al. Frequent expression of fibroblast growth factor-23 (FGF23) mRNA in aneurysmal bone cysts and chondromyxoid fibromas. J. Clin. Pathol. 2012; 65; 907-909.
19. Graham RP, Hodge JC, Folpe AL et al. A cytogenetic analysis of 2 cases of phosphaturic mesenchymal tumor of mixed connective tissue type. Hum. Pathol. 2012; 43; 1334-1338.
20. Mirra JM, Kessler S, Bhuta S et al. The fibroma-like variant of epithelioid sarcoma. A fibrohistiocytic/myoid cell lesion often confused with benign and malignant spindle cell tumors. Cancer 1992; 15; 1382-1395.
21. Billings SD, Folpe AL, Weiss SW. Epithelioid sarcoma-like hemangioendothelioma. Am. J. Surg. Pathol. 2003; 27; 48-57.
22. Hornick JL, Fletcher CD. Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior. Am. J. Surg. Pathol. 2011; 35; 190-201.
23. Trombetta D, Magnusson L, von Steyern FV et al. Translocation t(7;19)(q22;q13) - a recurrent chromosome aberration in pseudomyogenic hemangioendothelioma? Cancer Genet. 2011; 204; 211-215.
24. McGinity M, Bartanusz V, Dengler B et al. Pseudomyogenic hemangioendothelioma (epithelioid sarcoma-like hemangioendothelioma, fibroma-like variant of epithelioid sarcoma) of the thoracic spine. Eur. Spine J. 2013; 22(Suppl. 3); 506-511.
25. Amary MF, O'Donnell P, Berisha F et al. Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma; characterization of five cases. Skeletal Radiol. 2013; 42; 947-957.
26. Sheng W, Pan Y, Wang J. Pseudomyogenic hemangioendothelioma: report of an additional case with aggressive clinical course. Am. J. Dermatopathol. 2013; 35; 597-600.
27. Meis-Kindblom JM, Kindblom L-G. Acral myxoinflammatory fibroblastic sarcoma; a low-grade tumor of the hands and feet. Am. J. Surg. Pathol. 1998; 22; 911-924.
28. Montgomery EA, Devaney KO, Giordano TJ et al. Inflammatory myxohyaline tumor of distal extremities with virocyte or Reed-Sternberg-like cells: a distinctive lesion with features simulating inflammatory conditions, Hodgkin's disease, and various sarcomas. Mod. Pathol. 1998; 11; 384-391.
29. Michal M. Inflammatory myxoid tumor of the soft parts with bizarre giant cells. Pathol. Res. Pract. 1998; 194; 529-533.
30. Sakaki M, Hirokawa M, Wakatsuki S et al. Acral myxoinflammatory fibroblastic sarcoma: a report of five cases and review of the literature. Virchows Arch. 2003; 442; 25-30.
31. Lambert I, Debiec-Rychter M, Guelinckx P et al. Acral myxoinflammatory fibroblastic sarcoma with unique clonal chromosomal changes. Virchows Arch. 2001; 438; 509-512.
32. Hallor KH, Sciot R, Staaf J et al. Two genetic pathways, t(1:10) and amplification of 3p11-12, in myxoinflammmatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions. J. Pathol. 2009; 217; 716-727.
33. Antonescu CR, Zhang L, Nielsen GP et al. Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor. Genes Chromosom. Cancer 2011; 50; 757-764.
34. Fletcher CDM, Bridge JA, Lee JC. Extrapleural solitary fibrous tumour. In Fletcher CDM, Bridge JS, Pancras CW, Hogendoorn FM eds. WHO classification of tumours of soft tissue and bone. Lyon: IARC Press, 2013; 80-82.
35. Robinson DR, Wu YM, Kalyana-Sundaram S et al. Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat. Genet. 2013; 45; 180-185.
36. Chnielecki J, Crago AM, Rosenberg M et al. Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat. Genet. 2013; 45; 131-132.
37. Mohajeri A, Tayebwa J, Collin A et al. Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, non-random secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor. Genes Chromosom. Cancer 2013; 52; 873-886.
38. Doyle LA, Vivero M, Fletcher CD et al. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod. Pathol. 2013. [Epub ahead of print].
39. Schweizer L, Koelsche C, Sahm F et al. Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathol. 2013; 125; 651-658.
40. Fletcher CDM, Antonescu CR, Heim S et al. Myoepithelioma. In Fletcher CDM, Bridge JS, Pancras CW, Hogendoorn FM eds. WHO classification of tumours of soft tissue and bone. Lyon: IARC Press, 2013; 208-209.
41. Antonescu CR, Zhang L, Chang N-E et al. EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene. Genes Chromosom. Cancer 2010; 49; 1114-1124.
42. Hornick JL, Fletcher CD. Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters. Am. J. Surg. Pathol. 2003; 27; 1183-1196.
43. Brandal P, Panagopoulos I, Bjerkehagen B et al. Detection of a t(1;22)(q23;q12) translocation leading to an EWSR1-PBX1 fusion gene in a myoepithelioma. Genes Chromosom. Cancer 2008; 47; 558-564.
44. Brandal P, Panagopoulos I, Bjerkehagen B et al. t(19;22)(q13;q12) translocation leading to the novel fusion gene EWSR1-ZNF444 in soft tissue myoepithelial carcinoma. Genes Chromosom. Cancer 2009; 48; 1051-1056.
45. Yamaguchi S, Yamazaki Y, Ishikawa Y et al. EWSR1 is fused to POU5F1 in a bone tumor with translocation t(6;22)(p21;q12). Genes Chromosom. Cancer 2005; 43; 217-222.
46. Deng FM, Galvan K, de la Roza G et al. Molecular characterization of an EWSR1-POU5F1 fusion associated with a t(6;22) in an undifferentiated soft tissue sarcoma. Cancer Genet. 2011; 204; 423-429.
47. Möller E, Stenman G, Mandahl N et al. POU5F1, encoding a key regulator of stem cell pluripotency, is fused to EWSR1 in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands. J. Pathol. 2008; 215; 78-86.